DEFINITIVE CONTRACT
Active75F40126C00101
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$534K
obligated · signed 1 week ago
4 YEAR BAA CONTRACT- FY26C1AP5-ENHANCING REGULATORY CONFIDENCE IN PEDIATRIC BIOEQUIVALENCE THROUGH VALIDATED TIM BASED MECHANISTIC PLATFORMS AND MODEL INTEGRATED EVIDENCE
Performance timeline
Start
Nov 2, 2026
Current end
May 1, 2029
Potential end
Nov 1, 2030
with all options
Loading status
Estimated start: Nov 1, 2029
UNIVERSITY OF STRATHCLYDE
Contract 75F40126C00101
UEI
WF55FB5QTR96
Parent Company
UNIVERSITY OF STRATHCLYDE
Capabilities & Certifications
Headquarters Location
Current Obligation
$534,032
Base + Exercised Options
$534,032
Total Ceiling Value
$760,505
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.